RNAi Roundup: CytRx Names Full-time CFO; Genta to Enter RNAi Arena with Salus Acquisition; Nucleonics licenses RNAi Patent Applications from Wyeth; EURIT Sets Meeting for September 2 | GenomeWeb

NEW YORK, Aug. 22 (GenomeWeb News) - A year after it merged with Global Genomics, CytRx has found a permanent chief financial officer in Kirk Peacock, 35, who on Aug. 15 took the company's fiscal reins from interim-CFO and still-CEO Steve Kriegsman.   

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.